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Letters to the EditorAF. Unfortunately, alternative energy
sources used for the Cox maze IV
have not shown consistent results.3
We had the opportunity to compare 2
groups of patients who underwent
MV surgery and surgery for AF.
With regard to the AF, all the cases
were performed exclusively by the
cut-and-sew method to guarantee total
transmural lesions. One hundred pa-
tients underwent only isolation of the
pulmonary veins; 20 underwent a
Cox maze III procedure. All patients
were operated on by the same surgeon
(O.A.G.-V.). Sinus rhythm conversion
rate was immensely superior for the
Cox maze III group (19/20; 95%),
than for the pulmonary vein isolation
group (76/100; 76%) at 3 months’
follow-up. The prevalence of normal
sinus rhythm was higher in the Cox
maze III group at 6 months’ follow-
up (95% vs 54%). Although our
data have not yet been published, a
brief analysis of them shows that the
sole isolation of the pulmonary veins
is not enough to eliminate long-
standing persistent AF in the setting
of concomitant MV disease. In addi-
tion, the Cox maze III procedure
must be performed by the cut-and-
sew method, because this is the only
measure that will ensure transmural
lesions. Moreover, a biatrial lesion
set pattern is highly mandatory in the
Cox maze III procedure to eliminate
long-standing persistent AF.
Definitely, the standard cut-and-
sew Cox-maze III procedure remains
the best choice in surgery for AF,
especially for patients with MV
disease.
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To the Editor:
The noteworthy article by Singh
and coworkers,1 ‘‘Autophagy Gene
Fingerprint in Human Ischemia and
Reperfusion,’’1 recently published in
the Journal, illustrates the importance
of keeping surgeons informed about
potentially new approaches to treating
patients with heart disease. Although
the process of autophagy is well
known in the scientific community,
few cardiothoracic surgeons are aware
of its relevance to acquired heart
disease, general thoracic surgery, and
cardiothoracic transplantation.
This article brings to our attention
the accumulating evidence from
animal and human studies that cardiac
autophagy is an endogenous cellular
protective mechanism activated by
ischemic stress. Because ischemia-
reperfusion injury contributes to post-
operative morbidity and mortality in a
number of surgical settings, the pros-
pect of harnessing this pathway to
improve clinical outcome is highly
attractive. One obstacle to overcome
is the effective translation of preclini-
cal knowledge to clinical application.
The recent publication by Singh
and coworkers1 is a positive step
forward. These investigators conduc-
ted a comprehensive evaluation of
changes in expression of several
autophagy-related genes and upstream
regulators in 9 patients undergoing
coronary artery bypass grafting. Key
components of the autophagy pathwayof Thoracic and Cardiovascular Surgewere upregulated, including cysteine
protease Atg4 isoforms (Atg4A,
Atg4C, Atg4D), which contribute to
autophagosome formation by priming
LC3 for lipidation. The elevated
LC3II/LC3I ratio was interpreted as
an increase in cardiac autophagy.
Their conclusion, that cardiac auto-
phagy is induced in response to
ischemia/reperfusion, is consistent
with our 2013 observations2 in 19 pa-
tients undergoing heart surgery who
exhibited marked decreases in the
autophagy proteins p62/SQSTM1,
Beclin-1, Atg5-12, and LC3B. We
concluded that ischemia-reperfusion
injury was associated with a marked
acceleration in autophagic flux (clear-
ance). Of particular interest was the
decrease in p62, because this bifunc-
tional protein binds ubiquitinated tar-
gets and autophagosomal LC3. With
enhanced flux, the degradation of
autophagosomes and their cargo
increases, as reflected by depletion of
p62. We observed that decreases in
both LC3-I and LC3-II correlated
with a fall in p62 and that the magni-
tude of p62 depletion varied directly
with crossclamp time and inversely
with mortality and morbidity risk
scores. Why our findings with respect
to changes in LC3 and p62 differ
from those of Singh and coworkers1
is unclear, given our similar patient
demographics. One explanation could
lie with the differences in crossclamp
time (118 vs 78 minutes) and cardio-
pulmonary bypass time (145 vs 97
minutes); they were shorter in the
study of Singh and coworkers.1 The
key point is that both groups provide
translational information that supports
the concept that the homeostatic
intracellular repair response, or
adaptive autophagy, is active in
the human heart. This concept is
further supported byKassiotis and col-
leagues,3 who reported in 2009 that
left ventricular assist device
unloading of the failing human heart
was associated with a decrease in
autophagic activity, andGarcia and as-
sociates,4 who reported in 2012 thatry c Volume 148, Number 1 369
FIGURE 1. Margin cytology results in cases of pulmonary wedge resection for non–small cell lung
cancer according to tumor size and margin distance. Open circle represents malignant negative
cytology (n ¼ 104), and closed circle represents malignant positive cytology (n ¼ 53).
FIGURE 2. Methods of measuring margin length.
Letters to the Editoratrial autophagy was impaired in the
patients who had postoperative atrial
fibrillation after coronary artery
bypass grafting. These findings
provide hope that pharmacologic
activation of autophagy or the
manipulation of key autophagic
machinery–related molecules will
lead to new approaches to managing
heart failure related to ischemia-
reperfusion.
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MARGIN LENGTH IN
PULMONARY EXCISION OF
LUNG CANCER?
To the Editor:
I read with great interest the article
by DrMohiuddin and colleagues, enti-
tled ‘‘Relationship Between Margin
Distance and Local Recurrence370 The Journal of Thoracic and CAmong Patients Undergoing Wedge
Resection for Small (2 cm) Non-
Small Cell Lung Cancer.’’ The authors
stated that the distance from the
margin to the tumor (margin length)
of 1.5 cm was a critical point in wedge
resection cases according to the rate of
local recurrence and relapse-free
survival.1
I agreewith their opinionbecause, in
our experience, there are few margins
revealing malignant positive cytology
among patients who underwent wedge
resection for peripheral non–small cell
lung cancer with amargin length of 2.0
cm or greater (Figure 1). With our
method, after carrying out margin
cytology, the length is measured fromardiovascular Surgery c July 2014the cut edge of the stapled line,2-4
which may be approximately 0.5 cm
or greater than in the report by
Mohiuddin and colleagues.
There are different ways to measure
‘‘margin length,’’ as Goldstein and
colleagues5 pointed out: (1) pleural
surface-based margin distance, (2)
gross cut-surface margin distance,
and (3) microscopic margin distance
(Figure 2). Our choice is the pleural
surface-based margin distance,
whereas the latter 2 may be chosen
according to Mohiuddin and col-
leagues.1 There may be a discrepancy
of approximately 0.5 cm.
Obtaining a sufficient margin
length is the most important issue
